Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Left ventricular remodeling after myocardial infarction pathophysiology, diagnostic approach and management during Cardiac Rehabilitation

  • Marcos-Garcés, Víctor
  • Bertolín-Boronat, Carlos
  • Merenciano-Gonzalez, Héctor
  • Martínez Mas, Maria Luz
  • Climent Alberola, Josefa Inés
  • Lopez Bueno, Laura
  • Paya Rubio, Alfonso
  • Pérez-Solé, Nerea
  • Rios-Navarro, César
  • De Dios, Elena
  • Rodríguez-Palomares, Jose F.
  • Ortiz-Perez, Jose T.
  • Sanchis, Juan
  • Gavara-Doñate, Josep|||0000-0002-3483-7066
  • Moratal, David|||0000-0002-2825-3646
[EN] Despite the improvement in prognosis in patients with acute myocardial infarction (AMI), a significant proportion of survivors still experience heart failure (HF)-related adverse outcomes. Adverse left ventricular remodeling (LVR), which refers to a progressive dilation of left ventricular (LV) end-diastolic and end-systolic volumes, usually accompanied by a deterioration in LV systolic function, occurs frequently and underlies most cases of HF development after AMI. In this review, we discuss the current definitions of post-AMI LVR, the most appropriate imaging modalities for its detection, and the pathophysiological mechanisms by which Cardiac Rehabilitation (CR) can improve LVR-including exercise interventions, cardiovascular risk factors control, and pharmacological therapy optimization. Finally, we provide up-to-date recommendations for the follow-up and management of LVR in post-AMI patients enrolled in CR and outline future prospects on this topic., This research was funded by the Instituto de Salud Carlos III, Fondos Europeos de Desarrollo Regional FEDER and Fondo Social Europeo Plus (FSE+) (grant numbers PI23/01150, PI15/00531, CB16/11/00486, CB16/11/00420, and CB16/11/00479 and postgraduate contracts CM21/00175 and CM23/00246) and by Conselleria de Educacion of the Generalitat Valenciana (CIPROM/2024/028). Dr. Marcos-Garces acknowledges funding from the Instituto de Salud Carlos III and co-funding from Fondo Social Europeo Plus (FSE+) (grant JR23/00032), as well as a GE 2023 grant from the Conselleria de Innovacion, Universidades, Ciencia y Sociedad Digital of the Generalitat Valenciana (CIGE/2022/26). Dr. Ortiz-Perez acknowledges partial financial support from Fundacio La Marato de TV3 (grant number 20153030-31-32), Siemens Healthcare, and La Caixa Banking Foundation (HR17-00527). Dr. Gavara acknowledges funding from the Conselleria de Educacion-Generalitat Valenciana and co-funding from Fondo Social Europeo Plus (grant number CIAPOS/2023/247). Dr. Moratal has received financial support from the Conselleria d'Educacio, Investigacio, Cultura i Esport, Generalitat Valenciana (grants AEST/2019/037 and AEST/2020/029).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Magnetic Resonance Assessment of Left Ventricular Ejection Fraction at Any Time Post-Infarction for Prediction of Subsequent Events in a Large Multicenter STEMI Registry

  • Gavara-Doñate, Josep|||0000-0002-3483-7066
  • Moratal, David|||0000-0002-2825-3646
  • Marcos-Garces, Victor
  • Lopez-Lereu, Maria P.
  • Monmeneu, José V.
  • Rios-Navarro, César
  • De Dios, Elena
  • Pérez, Nerea
  • Merenciano, Héctor
  • Gabaldon, Ana
  • Cànoves, Joaquim
  • Racugno, Paolo
  • Bonanad, Clara
  • Miñana, Gema
  • Nunez, Julio
  • Nunez, Eduardo
[EN] Background Magnetic resonance imaging (MRI) is the most accurate imaging technique for left ventricular ejection fraction (LVEF) quantification, but as yet the prognostic value of LVEF assessment at any time after ST-segment elevation myocardial infarction (STEMI) for subsequent major adverse cardiac event (MACE) prediction is uncertain. Purpose To explore the prognostic impact of MRI-derived LVEF at any time post-STEMI to predict subsequent MACE (cardiovascular death or re-admission for acute heart failure). Study Type Prospective. Population One thousand thirteen STEMI patients were included in a multicenter registry. Field Strength/Sequence 1.5-T. Balanced steady-state free precession (cine imaging) and segmented inversion recovery steady-state free precession (late gadolinium enhancement) sequences. Assessment Post-infarction MRI-derived LVEF (reduced [r]: <40%; mid-range [mr]: 40%-49%; preserved [p]: >= 50%) was sequentially quantified at 1 week and after >3 months of follow-up. Statistical Tests Multi-state Markov model to determine the prognostic value of each LVEF state (r-, mr- or p-) at any time point assessed to predict subsequent MACE. A P-value During a 6.2-year median follow-up, 105 MACE (10%) were registered. Transitions toward improved LVEF predominated and only r-LVEF (at any time assessed) was significantly related to a higher incidence of subsequent MACE. The observed transitions from r-LVEF, mr-LVEF, and p-LVEF states to MACE were: 15.3%, 6%, and 6.7%, respectively. Regarding the adjusted transition intensity ratios, patients in r-LVEF state were 4.52-fold more likely than those in mr-LVEF state and 5.01-fold more likely than those in p-LVEF state to move to MACE state. Nevertheless, no significant differences were found in transitions from mr-LVEF and p-LVEF states to MACE state (P-value = 0.6). Data Conclusion LVEF is an important MRI index for simple and dynamic post-STEMI risk stratification. Detection of r-LVEF by MRI at any time during follow-up identifies a subset of patients at high risk of subsequent events. Level of Evidence 2 Technical Efficacy Stage 2, This work was supported by "Instituto de Salud Carlos III," "Fondos Europeos de Desarrollo Regional FEDER" (grants PI15/00531, PI17/01836, PI20/00637, and CIBERCV16/11/00486), and "Marato TV3" (grant 20153030-31-32), a grant from the Catalonian Society of Cardiology 2015 and a grant from La Caixa Foundation (HR17-00527). David Moratal and Jose Gavara acknowledge financial support from the "Conselleria d'Educacio, Investigacio, Cultura i Esport, Generalitat Valenciana" (grants AEST/2019/037 and AEST/2020/029), "Agencia Valenciana de la Innovacion, Generalitat Valenciana" (ref. INNCAD00/19/085 and INNCAD/2020/84), and "Centro para el Desarrollo Tecnologico Industrial" (Programa Eurostars-2, actuacion Interempresas Internacional), Spanish "Ministerio de Ciencia, Innovacion y Universidades" (ref. CIIP-20192020).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Ejection Fraction by Echocardiography for a Selective Use of Magnetic Resonance After Infarction

  • Marcos-Garces, Victor
  • Lopez-Lereu, Maria P.
  • Monmeneu, Jose V.
  • Rios-Navarro, Cesar
  • De Dios, Elena
  • Pérez, Nerea
  • Cànoves, Joaquim
  • Gonzalez, Jessika
  • Minana, Gema
  • Nunez, Julio
  • de la Espriella, Rafael
  • Santas, Enrique
  • Chorro, Francisco J.
  • Gavara-Doñate, Josep|||0000-0002-3483-7066
  • Moratal, David|||0000-0002-2825-3646
[EN] Background Cardiac magnetic resonance (CMR) permits robust risk stratification of discharged ST-segment-elevation myocardial infarction patients, but its indiscriminate use in all cases is not feasible. We evaluated the utility of left ventricular ejection fraction (LVEF) by echocardiography for a selective use of CMR after ST-segment-elevation myocardial infarction. Methods Echocardiography and CMR were performed in 1119 patients discharged for ST-segment-elevation myocardial infarction included in a multicenter registry. The prognostic power of CMR beyond echocardiography-LVEF was assessed using adjusted C statistic, net reclassification improvement index, and integrated discrimination improvement index. Results During a 4.8-year median follow-up, 136 (12%) first major adverse cardiac events (MACE) occurred (47 cardiovascular deaths and 89 readmissions for acute heart failure). In the entire group, CMR-LVEF (but not echocardiography-LVEF) independently predicted MACE occurrence. The MACE rate significantly increased only in patients with CMR-LVEF<40% (>= 50%: 7%, 40%-49%: 9%, <40%: 27%, P<0.001). Most patients displayed echocardiography-LVEF >= 50% (629, 56%), and they had a low MACE rate (57/629, 9%). In patients with echocardiography-LVEF<50% (n=490, 44%), the MACE rate was also low in those with CMR-LVEF >= 40% (24/278, 9%) but significantly increased in patients with CMR-LVEF<40% (55/212, 26%; P<0.001). Compared with echocardiography-LVEF, CMR-LVEF significantly improved MACE prediction in the group of patients with echocardiography-LVEF<50% (C statistic, 0.80 versus 0.72; net reclassification improvement index, 0.73; integrated discrimination improvement index, 0.10) but not in those with echocardiography-LVEF >= 50% (C statistic 0.66 versus 0.66; net reclassification improvement index, 0.17; integrated discrimination improvement index, 0.01). Conclusions A straightforward strategy based on a selective use of CMR for risk prediction in ST-segment-elevation myocardial infarction patients with echocardiography-LVEF<50% can provide insights into patient care. The cost-effectiveness of this approach, as well as the direct implications in clinical management, should be further explored., This work was supported by Instituto de Salud Carlos III and Fondos Europeos de Desarrollo Regional FEDER (grant numbers PI15/00531, PI17/01836, PI20/00637 and, CIBERCV16/11/00486), Marato TV3 (grant number 20153030-31-32), a grant from the Catalonian Society of Cardiology 2015, and Generalitat Valenciana (grant number GV/2018/116). The study was partially funded by Siemens Healthcare, which provided financial support to conduct CMR studies in 94 subjects of this series. D.M. acknowledges financial support from the Agencia Valenciana de la Innovacion, Generalitat Valenciana (grant number INNCAD00/19/085), and from the Conselleria d'Educacio, Investigacio, Cultura i Esport, Generalitat Valenciana (grant number AEST/2019/037).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Risk score for early risk prediction by cardiac magnetic resonance after acute myocardial infarction

  • Marcos-Garcés, Víctor
  • Perez, Nerea
  • Lopez-Lereu, Maria P.
  • Monmeneu, Jose V.
  • Rios-Navarro, Cesar
  • de Dios, Elena
  • Merenciano-González, Hector
  • Gabaldon-Perez, Ana
  • Cànoves, Joaquim
  • Racugno, Paolo
  • Bonanad, Clara
  • Miñana, Gema
  • Nunez, Julio
  • Gavara-Doñate, Josep|||0000-0002-3483-7066
  • Moratal, David|||0000-0002-2825-3646
[EN] Background: Cardiac magnetic resonance (CMR) performed early after ST-segment elevation myocardial infarction (STEMI) can improve major adverse cardiac event (MACE) risk prediction. We aimed to create a simple clinical-CMR risk score for early MACE risk stratification in STEMI patients. Methods: We performed a multicenter prospective registry of reperfused STEMI patients (n = 1118) in whom early (1-week) CMR-derived left ventricular ejection fraction (LVEF), infarct size and microvascular obstruction (MVO) were quantified. MACE was defined as a combined clinical endpoint of cardiovascular (CV) death, nonfatal myocardial infarction (NF-MI) or re-admission for acute decompensated heart failure (HF). Results: During a median follow-up of 5.52 [2.63-7.44] years, 216 first MACE (58 CV deaths, 71 NF-MI and 87 HF) were registered. Mean age was 59.3 +/- 12.3 years and most patients (82.8%) were male. Based on the four variables independently associated with MACE, we computed an 8-point risk score: time to reperfusion >4.15 h (1 point), GRACE risk score > 155 (3 points), CMR-LVEF <40% (3 points), and MVO >1.5 segments (1 point). This score permitted MACE risk stratification: MACE per 100 person-years was 1.96 in the low-risk category (0-2 points), 5.44 in the intermediate-risk category (3-5 points), and 19.7 in the high-risk category (6-8 points): p < 0.001 in multivariable Cox survival analysis. Conclusions: A novel risk score including clinical (time to reperfusion >4.15 h and GRACE risk score > 155) and CMR (LVEF <40% and MVO >1.5 segments) variables allows for simple and straightforward MACE risk stratification early after STEMI. External validation should confirm the applicability of the risk score., This work was supported by the Instituto de Salud Carlos III and cofunded by Fondo Europeo de Desarrollo Regional (FEDER) (grants PI20/00637 and CIBERCV16/11/00486), "Marató TV3" [grant number 20153030-31-32], the Catalonian Society of Cardiology 2015, La Caixa Foundation [HR17-00527], and by Sociedad Española de Cardiología (grant SEC/FECINV-CLI 21/024). D.M. acknowledges financial support from the Conselleria d'Educació, Investigació, Cultura i Esport, Generalitat Valenciana (grants AEST/ 2019/037 and AEST/2020/029). J. G. acknowledges financial support from the Agencia Estatal de Investigación (grant FJC2020-043981-I / AEI/10.13039/501100011033).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Prognostic value of cardiac magnetic resonance early after ST-segment elevation myocardial infarction in older patients

  • Gabaldón-Pérez A
  • Marcos-Garcés, Víctor
  • López-Lereu, María P.
  • Monmeneu, José V.
  • Pérez, Nerea
  • Ríos-Navarro, César
  • De Dios, Elena
  • Merenciano-González, Héctor
  • Cànoves, Joaquim
  • Racugno, Paolo
  • Bonanad, Clara
  • Minana, Gema
  • Núnez, Julio
  • Gavara-Doñate, Josep|||0000-0002-3483-7066
  • Moratal, David|||0000-0002-2825-3646
[EN] Background older patients with ST-segment elevation myocardial infarction (STEMI) represent a very high-risk population. Data on the prognostic value of cardiac magnetic resonance (CMR) in this scenario are scarce. Methods the registry comprised 247 STEMI patients over 70 years of age treated with percutaneous intervention and included in a multicenter registry. Baseline characteristics, echocardiographic parameters and CMR-derived left ventricular ejection fraction (LVEF, %), infarct size (% of left ventricular mass) and microvascular obstruction (MVO, number of segments) were prospectively collected. The additional prognostic power of CMR was assessed using adjusted C-statistic, net reclassification index (NRI) and integrated discrimination improvement index (IDI). Results during a 4.8-year mean follow-up, the number of first major adverse cardiac events (MACE) was 66 (26.7%): 27 all-cause deaths and 39 re-admissions for acute heart failure. Predictors of MACE were GRACE score (HR 1.03 [1.02-1.04], P < 0.001), CMR-LVEF (HR 0.97 [0.95-0.99] per percent increase, P = 0.006) and MVO (HR 1.24 [1.09-1.4] per segment, P = 0.001). Adding CMR data significantly improved MACE prediction compared to the model with baseline and echocardiographic characteristics (C-statistic 0.759 [0.694-0.824] vs. 0.685 [0.613-0.756], NRI = 0.6, IDI = 0.08, P < 0.001). The best cut-offs for independent variables were GRACE score > 155, LVEF < 40% and MVO >= 2 segments. A simple score (0, 1, 2, 3) based on the number of altered factors accurately predicted the MACE per 100 person-years: 0.78, 5.53, 11.51 and 78.79, respectively (P < 0.001). Conclusions CMR data contribute valuable prognostic information in older patients submitted to undergo CMR soon after STEMI. The Older-STEMI-CMR score should be externally validated., This work was supported by Instituto de Salud Carlos III and Fondos Europeos de Desarrollo Regional FEDER (grant numbers PI20/00637, PI15/00531, and CIBERCV16/11/00486,CIBERCV16/11/00420, CIBERCV16/11/00479), apostgraduate contract FI18/00320 to C.R.-N., CM21/00175 to V.M.-G. and JR21/00041 to C.B., Fundacio La MaratoTV3 (grant 20153030-31-32), La Caixa Banking Foundation (HR17-00527), by Conselleria de Educacion-Generalitat Valenciana (PROMETEO/2021/008) and by Sociedad Espanola de Cardiologia (grant SEC/FEC-INV-CLI 21/024). J.G. acknowledges financial support from the Agencia Estatal de Investigacion (grant FJC2020-043981-I/AEI/10.13039/501100011033). D.M. acknowledges financial support from the Conselleria d'Educacio,Investigacio, Cultura i Esport, Generalitat Valenciana (grants AEST/2019/037, AEST/2020/029).